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Genetic and environmental factors have been widely suggested to contribute to the pathogenesis of
primary biliary cirrhosis (PBC), an autoimmune disease of unknown etiology leading to destruction
of small bile ducts. Interestingly, epidemiologic data indicate a variable prevalence of the disease in
different geographical areas. The study of clusters of PBC may provide clues as to possible triggers
in the induction of immunopathology. We report herein four such unique PBC clusters that suggest the
presence of both genetic and environmental factors in the induction of PBC. The ﬁrst cluster is
represented by a family of ten siblings of Palestinian origin that have an extraordinary frequency of
PBC (with 5/8 sisters having the disease). Second, we describe the cases of a husband and wife, both
having PBC. A family in which PBC was diagnosed in two genetically unrelated individuals, who lived
in the same household, represents the third cluster. Fourth, we report a high prevalence of PBC cases in
a very small area in Alaska. Although these data are anedoctal, the study of a large number of such
clusters may provide a tool to estimate the roles of genetics and environment in the induction of
autoimmunity.
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INTRODUCTION
Primary biliary cirrhosis (PBC) is an autoimmune disease
characterized by a female preponderance (9:1 female to
male ratio) with most cases occurring between 40 and 60
years of age (Kaplan, 1996). Autoantibodies to mitochon-
drial antigens (AMA) are detectable in 85–95% of cases
of PBC and often occur long before clinical signs or
symptoms appear; this test appears to be highly speciﬁc
for PBC (Kaplan, 1996). The autoantigens reactive against
AMA have been identiﬁed as subunits of a functionally
related family of enzymes, the 2-oxo-acid dehydrogen-
ases, and particularly as pyruvate dehydrogenase E2
(PDC-E2), oxoglutaric dehydrogenase E2 (OGDC-E2),
and branched-chain a-ketoacid dehydrogenase E2
(BCOADC-E2) (Gershwin et al., 2000). Liver histology
in patients with PBC shows progressive destruction of
small intrahepatic bile ducts, and ultimately cirrhosis; four
histological stages are described accordingly, spanning
from mild inﬂammatory inﬁltrate to frank liver cirrhosis
(Ludwig et al., 1978).
The genetic background appears important in deter-
mining the susceptibility and possibly the severity of
PBC (Tanaka et al., 2001). In the case of major
histocompatibility complex (MHC) variants, for
example, the associations demonstrated for other
autoimmune diseases have not been conﬁrmed in PBC
or appear to be limited to certain geographical areas
(Donaldson et al., 1994; Agarwal et al., 1999; Tanaka
et al., 2001). Beside genetic predisposition, a number of
environmental factors, including molecular mimicry by
either microorganisms or xenobiotics have also been
proposed (Long et al., 2001; Van de Water et al., 2001;
Long et al., 2002; Palmer et al., 2002). One resulting
hypothesis is that environmental factors may trigger PBC
in genetically predisposed individuals. Several studies, in
fact, indicate that family members of known cases with
PBC present a signiﬁcantly higher risk of developing the
disease (Tsuji et al., 1999). Population-based studies
attempting to estimate the prevalence and incidence of
PBC have introduced the concept of geoepidemiology of
the disease, with higher prevalence in England and
Sweden, although a number of biases could not be ruled
out (Parikh-Patel et al., 1999). Available evidence
estimating the prevalence and incidence of PBC
in different geographical areas is shown in Table I.
The study of clusters of well-deﬁned PBC cases may
provide a helpful tool to estimate the relative roles of
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clusters described herein are examples of how these two
factors can be studied.
MATERIALS AND METHODS
Deﬁnition of PBC
The diagnosis of PBC was in all cases performed
according to internationally accepted criteria (Kaplan,
1996). Brieﬂy, two out of three conditions (elevated serum
alkaline phoshatase for longer than 6 months, positivity
for anti-mitochondrial antibodies, or diagnosis at histo-
logy) had to be fulﬁlled to conﬁrm the diagnosis of PBC.
Determination of AMA Reactivity
AMA determination was performed using recombinant
mitochondrialproteinsaspreviouslydescribed(Miyakawa
et al., 2001). Sera presenting reactivity at titre higher
than 1:80 against one or more of the recombinant proteins
(PDC-E2, BCOADC-E2, OGDC-E2) were considered to
be AMA positive.
Clusters of PBC
The characteristics of the subjects included in the four
clusters are summarized in Table II.
Cluster 1
A family of ten siblings (age range 27–49 years) of
Palestinian origin currently living in the same area have an
extraordinary high prevalence of PBC. We collected blood
samples from all 8 sisters and 2 brothers, as well as from
the mother, and tested sera for AMA, using recombinant
mitochondrial antigens as previously described
(Miyakawa et al., 2001). Five sisters (age range 27–47
years) presented a conﬁrmed clinical diagnosis of PBC
within a 10-year interval (1992–2002), including the
presence of high titre AMA with similar patterns of
reactivity and clinical stages of disease. Two other sisters
had weak AMA reactivity, but no other evidence of PBC.
Only one sister, both brothers, as well as the mother had
neither detectable AMA reactivity nor signs of PBC. Eight
different commercially available polymorphic micro-
satellite markers (Map Pairs, Res Gen, Invitrogen corp,
Carlsbad, CA) were tested to study the parentage of
this family. Six markers are located on six
different chromosomes (D4S1647, D5S815, D7S796,
D10S1146, D21S1910, D22S683), while 2 are found
on chromosome 6 close to the HLA loci (D6S265,
D6S299). Genotypes were determined using PCR
ampliﬁcation of 10ng of genomic DNA in 25ml
total volume reactions. PCR solution included 10mM
dNTP mix, 25mM MgCl2 solution, 10 £ PCR
Gold Buffer, 1 Unit of AmpliTaq GoldTM polymerase
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S. ABU-MOUCH et al. 128(Applied Biosystems, Foster City, CA, USA), 20uM of
each primer, and DNAase-RNAase-free water up to
a2 5 ml volume. Forward primers were labeled with
ATP(y-33P) (Perkin Elmer, Boston, MA, USA) using a T4
Polynucleotide Kinase system (Invitrogen). Ampliﬁcation
was carried out using Programmable Thermal Controller
(MJ Research Inc., Walthamm MA, USA) under the
following conditions: 100 denaturation at 948C; 9 cycles of
4500 at 948C, 4500 at 588Ct o5 0 8C( 218C per cycle), 6000 at
728C; 35 cycles of 4500 at 948C, 4500 at 508C, 6000 at 728C,
followed by 70 at 728C. Upon completion of PCR, 1mlo f
product was taken and added to 15ml of dye and water and
heated for 5min at 958C. Finally, 3ml of product/dye
solution were run onto a 7% polyacrylamide Bio-Rad
Sequencing Gel (Bio-Rad Laboratories, Inc., Hercules,
CA, USA) for 3h at 60W and then transferred to a
Molecular Dynamics Phosphor Screen (Amersham
Biosciences, Piscataway, NJ, USA). Gel results were
analyzed using ImageQuaNT by Molecular Dynamics
(Amersham Biosciences). The patterns obtained from the
10 siblings were fully compatible with a complete
brotherhood (Pena and Chakraborty, 1994).
Cluster 2
A case of husband and wife, both with a well-
characterized diagnosis of PBC, live in the Northwestern
region of the US. Disease developed after their marriage
with diagnosis ﬁve years apart from each other (both
individuals were 43 at the time of diagnosis). Despite
being ﬁve years younger and being diagnosed ﬁve years
after his wife, the male patient currently presents a
histologically-proven more advanced disease. Interest-
ingly, they were born in the same street of the same large
city in the state of Michigan, without knowing each other
for decades, and that the only recognizable possible risk
factor for both individuals was previous cigarette
smoking. Other proposed risk factors for PBC were also
investigated and, interestingly, recurrent urinary tract
infections were reported only by the female subject.
Cluster 3
We describe a family from the state of New York in which
the grandmother (our index case) had the diagnosis of
PBC established in 1977. Her daughter, who remains
asymptomatic, has shown a similar AMA pattern with a
rising titer over 13 years. Interestingly, however, and
suggesting a role for environmental factors in this cluster,
we report the development of PBC in the daughter-in-law
of our index case; this woman emigrated to the US from
Korea and livedinthe same household for two years and in
the same neighborhood for over thirty years before being
also diagnosed with PBC. Her daughter (granddaughter of
our index case) was found to be repeatedly positive for
AMA (with titres increasing over the past 14 years)
without showing any other evidence of PBC. Clinically,
the two deﬁned cases present very different degrees of
disease severity.
Cluster 4
We describe a cluster of women with PBC in an area
including two small cities in the state of Alaska (female
population 4.588 in 2000). Between 1973 and 2001,
6 cases of PBC were diagnosed according to internation-
ally accepted criteria among people currently or
previously living for at least 10 years in that area.
TABLE II Characteristics of the subjects included in the four PBC clusters
Cluster Subject Year of birth AMA PBC (year of diagnosis)
1 Mother 1937 NEG 2
1st daughter 1954 POS 2
2nd daughter 1956 POS + (1992)
3rd daughter 1960 POS + (1996)
4th daughter 1963 POS + (1997)
5th daughter 1965 POS + (2002)
6th daughter 1968 NEG 2
7th daughter 1973 POS 2
8th daughter 1976 POS + (2001)
1st son 1958 NEG 2
2nd son 1970 NEG 2
2 Wife 1947 POS + (1990)
Husband 1952 POS + (1995)
3 Grandmother 1911 POS + (1977)
Daughter 1931 POS 2
Daughter in-law 1931 POS + (1987)
Granddaughter 1964 POS 2
4 Patient #1 1940 POS + (2000)
Patient #2 1935 POS + (1998)
Patient #3 1956 POS + (2001)
Patient #4 1935 POS + (2000)
Patient #5 1932 ? + (1973)
Patient #6 1951 POS + (1992)
PBC CLUSTERS 129Three of these cases, interestingly, had been working
together as phone operators for several years before the
diagnosis was made.
In order to estimate the prevalence of PBC in such area,
we considered only the cases who were diagnosed during
their residence in the area and still alive in 2000. Four
cases (age range 44–65 years) fulﬁlled the criteria and all
presented signs of early disease (histological stages I–II
according to Ludwig et al
3); the ethnicity was Caucasian
in three cases and Native American in one patient. While
the available data show that the prevalence of PBC is the
US is expected to be 402/million (Kim et al., 2000), the
frequency among women population in the Alaskan area
in 2000 can be estimated to be 870 per million.
DISCUSSION
Factors conferring susceptibility to PBC or triggering
autoimmunity remain poorly understood. Epidemiological
data seem conﬂicting in determining the importance of
genetic versus environmental factors. In fact, while PBC
prevalence seem to present a geographical distribution
(Table I), thus suggesting a strong role for exogenous
factors(Parikh-Pateletal.,1999), otherdata indicatea risk
of developing the disease for a ﬁrst-degree relative of an
affected subject much higher compared to other auto-
immune diseases, thus stressing a genetic susceptibility
(Tsuji et al., 1999). Beside this latter observation, relatives
ofaffectedindividualsseemtodevelopthediseasewithina
shorttimefromtheﬁrstcase,thuspossiblyindicatingagain
some environmental inﬂuence (Tsuji et al., 1999). Many
studies have concentrated on genetic factors in patients
with PBC (Tanaka et al., 2001) while most evidence about
otherfactorscomesfromexperimentalstudies(Longetal.,
2001; Leung et al., 2003; Xu et al., 2003).
A discrete number of genetic variants have been
associated with the disease, although no deﬁnitive
conclusion was reached. The strong association with
HLA molecules observed in other autoimmune diseases
has been not found in PBC and data about this aspect are
either conﬂicting or apparently geographically limited
(Tanaka et al., 2001). Other polymorphisms have been
indicated as able to confer susceptibility or to inﬂuence the
progressionofthediseasebutalsointhesecases,resultsare
generally debated, conﬂicting, or non conclusive (Donald-
son et al., 1994; Agarwal et al., 1999; Tanaka et al., 2001).
Most data indicating an environmental inﬂuence in
determining PBC have been collected for microorganisms
and xenobiotics. Several lines of evidence support a role
for infectious agents, especially bacteria and retroviruses,
in the pathogenesis of PBC (van de Water et al., 2001;
Xu et al., 2003). The microbial mechanism termed
“molecular mimicry” is a hypothesis forwarded to account
for breaking tolerance against mitochondrial antigens (van
de Water et al., 2001).
Xenobiotics are foreign compounds that may either
alterorcomplextodeﬁnedselfproteins,inducingachange
in the molecular structure of the native protein sufﬁcient to
induce an immune response. Such immune responses may
then result in the recognition of not only the modiﬁed
protein, but also the native form. The chronic presence of
the self-protein may thereafter perpetuate the immune
response initiated by the xenobiotic-induced adduct thus
leading to chronic autoimmunity. Beside the proposed role
for microorganisms, experimental data have also shown a
possible a role for some halogenated compounds in the
induction of AMA and possibly of PBC (Long et al., 2001;
Leung et al., 2003).
It is interesting to note familiar or environmental
clusters of PBC cases which could, in a similar fashion as
non-population based twin studies (comparing concor-
dance rates among monozygotic and dizygotic twins),
provide an estimate of the role of individual and
exogenous factors in determining susceptibility to multi-
factorial diseases such as PBC. The only case of non-
familiar cluster of PBC reported so far described an
individual nursing a patient with PBC and later developing
the disease (Douglas and Finlayson, 1979). We therefore
report herein four interesting clusters of patients with
PBC, although contrasting in their possible implications.
It is interesting to note that in cluster #1 the mother of the
offspring does not have any sign of PBC, indicating either
that responsible genes could be of paternal origin or the
presence of some environmental trigger that appeared or
became active only in the later generation. In a similar
fashion, cluster #3 cannot be explained only by genetic
inﬂuence, because of the case occurred in the woman of
Korean origin. It is worth to notice, moreover, that
unpublished data seem to indicate averylow prevalence of
PBC in the Korean region (Dr Hee-Sik Sun, Catholic
University in Seoul, personal communication). Clusters #2
and #4, on the other hand, clearly indicate a role for non-
individual factors, possibly represented by the household
(cluster #2) or by the geographical area (cluster #4), as
suggested in the past by some epidemiological data from
English studies (Triger, 1980; Prince et al., 2001). In three
of the clusters described herein, a role for genetics seems
unlikely because of the lack of consanguinity between the
spouses (cluster #2) or the two women with PBC in cluster
#3, and the different ethnic groups among the Alaskan
patients (cluster #4). In cluster #2, information obtained
about proposed risk factors for PBC (Parikh-Patel et al.,
2001) showed how in this particular case, history of
recurrent urinary tract infections was not found in both
individuals. Some unknown risk factors related with the
professional history might be present in half of the cases in
the Alaskan area. However, while the prevalence of PBC
in this region has never been investigated, it should be
noted that the estimated prevalence for PBC in the region
of cluster #4 was found to be the highest ever reported for
the disease (Parikh-Patel et al., 1999). Finally, we note
that these cases suggest once again that PBC shares key
genetic and environmental factors, as well as suggesting a
sort of ‘multi-hit’ pathogenesis (Donaldson et al., 2001).
The study of a signiﬁcant number of such clusters may
S. ABU-MOUCH et al. 130provide a tool to assess the relative roles of genetics and
environment in the induction of PBC.
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